Breaking News
FONT-SIZE Plus   Neg
Share SHARE

CVC Capital Partners, ValueAct Continue To Consider Options In Respect Of Misys

Funds advised by CVC Capital Partners Ltd. and ValueAct Capital Master Fund, L.P. noted the recent announcement by Vista of its recommended cash offer for Misys Plc (MSY.L, MUSJF.PK).

Misys had announced today that it agreed to be acquired by an investment vehicle owned by US-based private equity firm Vista Equity Partners for 350 pence per share, totaling about 1.3 billion pounds.

CVC and ValueAct continue to consider their options in respect of Misys, including a possible recommended joint cash offer for the company and urge Misys shareholders to take no action at this time.

However, there can be no certainty that an offer will be made by CVC and ValueAct, nor, if made, that a deal will result.

Click here to receive FREE breaking news email alerts for Misys plc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
This organic and natural products company has experienced strong compounded annual growth over the last four fiscal years with its net sales growing 25% and adjusted income from continuing operations over 30%. Here is a quick summary of the earnings reported after the bell on Nov. 24. 1. Amira Nature Foods Ltd (ANFI) reported net income for the second quarter of $8.3 million or $0.29 per share, compared to $5.0 million or $0.18 per share for the year-ago quarter. Excluding items, adjusted earnings... Cloud-based human resource software maker Workday, Inc. said Monday after the markets closed that its third quarter net loss widened from last year, as higher costs and expenses more than offset a 68% increase in revenue. However, the company's adjusted loss per share was smaller than what analysts estimated and its quarterly revenue topped analysts' forecast.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.